Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
ASU vs Chondroitin: Chondroitin has the stronger overall evidence (5.5 vs 5.5/10); they're alternatives for joint health & mobility — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Chondroitin wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Probably helps
2 of 3 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both ASU and Chondroitin have evidence — compare verdict strength side-by-side.
300mg ASU daily (standardized avocado:soybean unsaponifiables) (no cited trial states the dose it used, the cited papers are reviews and meta-analyses)
With meals
Standardized ASU (300mg)
800-1200mg
With meals, Once daily or split into 2-3 doses
Chondroitin sulfate from bovine or marine sources
1-3 months
1-3 months
Throughout use
8-12 weeks
12+ weeks
6-24 months
Efficacy and safety of avocado-soybean unsaponifiables for the treatment of hip and knee osteoarthritis: A systematic review and meta-analysis of randomized placebo-controlled trials.
Int J Rheum Dis (2019) · Meta analysis
A subanalysis according to the type of OA showed that ASU significantly decreased both VAS and Lequesne index in knee OA (WMD: -17.36, 95% CI: -25.91, -8.82; P < .0001 and WMD: -2.33, 95% CI: -2.88, -1.78; P < .00001, respectively) but not in hip OA.
Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials.
Osteoarthritis Cartilage (2008) · Meta analysis
Four trials were included, with 664 OA patients with either hip (41.4%) or knee (58.6%) OA allocated to either 300 mg ASU (336) or placebo (328).
Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis.
Br J Sports Med (2018) · Meta analysis
Of 20 supplements investigated in 69 eligible studies, avocado soybean unsaponifiables revealed statistically significant improvements on pain, but were of unclear clinical importance.
Meta-analysis: chondroitin for osteoarthritis of the knee or hip
Annals of internal medicine (2007) · Meta analysis · n=3846
Meta-analysis of 20 trials with 3,846 patients with knee or hip osteoarthritis, with very high heterogeneity (I2 92%).
The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review
Nutrients (2025) · Systematic review · n=146
Of the 2013 articles screened, 146 studies were included in our review, with nearly 60% being randomized controlled trials and most conducted in Europe, Asia, or the U.S.
Systematic review and network meta-analysis on the efficacy and safety of parmacotherapy for hand osteoarthritis
PloS one (2024) · Meta analysis · n=3965
GCSB-5, a specific herbal complex that mainly regulate pain in hand osteoarthritis, showed the greatest reduction in pain [WMD = -13.00, 95% CI (-26.69, 0.69)].
The 800 mg point is a 2-year placebo-controlled trial in 622 people with knee osteoarthritis (PMID 19180484), where pain improved faster than on placebo as a secondary outcome and joint space loss was smaller. The 1,200 mg point is the GAIT trial of 1,583 people (PMID 16495392), where chondroitin alone was not significantly better than placebo for a 20% fall in knee pain (5.3 percentage points higher, P=0.17), so it is plotted flat, not higher. A meta-analysis restricted to large, sound trials found no effect on pain (PMID 17438317), and the Cochrane review found a small benefit in short, mostly low-quality trials (PMID 25629804). Side effects matched placebo in both trials. No trial compared doses.
AI-estimated from published studies. Interpret as directional guidance.
Chondroitin has a higher evidence score (5.5/10 vs 5.5/10) and wins in 1 of 3 categories.
For joint health & mobility, Chondroitin has a higher relevance score (85 vs 60).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.